The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC-GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
Takeshi HatanakaAtsushi NaganumaAtsushi HiraokaToshifumi TadaMasashi HirookaKazuya KariyamaJoji TaniMasanori AtsukawaKoichi TakaguchiEi ItobayashiShinya FukunishiKunihiko TsujiToru IshikawaKazuto TajiriHironori OchiSatoshi YasudaHidenori ToyodaChikara OgawaTakashi NishimuraNoritomo ShimadaKazuhito KawataHisashi KosakaSatoru KakizakiTakaaki TanakaHideko OhamaKazuhiro NousoAkihiro MorishitaAkemi TsutsuiTakuya NaganoNorio ItokawaTomomi OkuboTaeang AraiMichitaka ImaiYohei KoizumiShinichiro NakamuraMasaki KaiboriHiroko IijimaYoichi HiasaTakashi Kumadanull nullPublished in: Cancer medicine (2022)
The HCC-GRIm score serves as a novel prognostic score for HCC patients treated with Atez/Bev.
Keyphrases